Article Versions Notes

de Oliveira MG, Monica FZ, Passos GR, Victorio JA, Davel AP, Oliveira ALL, Parada CA, D’Ancona CAL, Hill WG, Antunes E. Selective Pharmacological Inhibition of NOX2 by GSK2795039 Improves Bladder Dysfunction in Cyclophosphamide-Induced Cystitis in Mice. Antioxidants. 2023; 12(1):92. https://doi.org/10.3390/antiox12010092

de Oliveira, Mariana G., Fabíola Z. Monica, Gabriela R. Passos, Jamaira A. Victorio, Ana Paula Davel, Anna Lethicia Lima Oliveira, Carlos A. Parada, Carlos A. L. D’Ancona, Warren G. Hill, and Edson Antunes. 2023. "Selective Pharmacological Inhibition of NOX2 by GSK2795039 Improves Bladder Dysfunction in Cyclophosphamide-Induced Cystitis in Mice" Antioxidants 12, no. 1: 92. https://doi.org/10.3390/antiox12010092

de Oliveira, M. G., Monica, F. Z., Passos, G. R., Victorio, J. A., Davel, A. P., Oliveira, A. L. L., Parada, C. A., D’Ancona, C. A. L., Hill, W. G., & Antunes, E. (2023). Selective Pharmacological Inhibition of NOX2 by GSK2795039 Improves Bladder Dysfunction in Cyclophosphamide-Induced Cystitis in Mice. Antioxidants, 12(1), 92. https://doi.org/10.3390/antiox12010092